Skip to main content
. 2016 Jun 28;115(2):188–194. doi: 10.1038/bjc.2016.185

Figure 1.

Figure 1

Total OS in patients who received 2L therapy. Gem=gemcitabine; HR=hazard ratio; nab-P=nab-paclitaxel.